Wave Life Sciences (WVE) Change in Cash (2016 - 2026)
Wave Life Sciences (WVE) has disclosed Change in Cash for 12 consecutive years, with -$57.5 million as the latest value for Q1 2026.
- For Q1 2026, Change in Cash rose 2.58% year-over-year to -$57.5 million; the TTM value through Mar 2026 reached $301.6 million, up 384.74%, while the annual FY2025 figure was $300.0 million, 194.77% up from the prior year.
- Change in Cash hit -$57.5 million in Q1 2026 for Wave Life Sciences, down from $405.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $405.9 million in Q4 2025 and bottomed at -$88.9 million in Q1 2022.
- Average Change in Cash over 5 years is $23.2 million, with a median of -$19.4 million recorded in 2024.
- On a YoY basis, Change in Cash climbed as much as 4682.88% in 2025 and fell as far as 203.87% in 2025.
- Wave Life Sciences' Change in Cash stood at -$8.5 million in 2022, then surged by 815.0% to $60.4 million in 2023, then crashed by 114.66% to -$8.9 million in 2024, then surged by 4682.88% to $405.9 million in 2025, then plummeted by 114.16% to -$57.5 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods came in at -$57.5 million, $405.9 million, and -$12.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.